Clinical Trials Logo

Sclerosis clinical trials

View clinical trials related to Sclerosis.

Filter by:

NCT ID: NCT04964791 Recruiting - Clinical trials for Relapsing Multiple Sclerosis

RMS Study of BTK Inhibitor SAR442168

Start date: August 1, 2020
Phase:
Study type: Observational

To access SAR442168 in the RMS populstion. Efficaty will be accessed by adjudicated relapse rate, disability progression, and MRI findings of disease activity.

NCT ID: NCT04964336 Recruiting - Multiple Sclerosis Clinical Trials

An Observational Study to Investigate the Role of B Cells in Multiple Sclerosis

Start date: February 5, 2018
Phase:
Study type: Observational

Multiple sclerosis (MS) typically afflict young people in their twenties, when they start a career and establish a family. The disease thus imposes a severe impact on quality of life and heavy economic burdens on society. Critical barriers to progress in the field are the lack of knowledge of relevant immune cell subsets driving the pathology and the targets of the immune response within the central nervous system. In this project, we will test the hypothesis that a subgroup of MS patients is defined by a genetically determined B cell response against specific antigenic epitopes. The hypothesis is based on our recent, pioneering results showing that approximately half of MS patients have a restricted population of B cells in the cerebrospinal fluid defined by polymorphisms in the constant heavy-chain of the immunoglobulin B cell receptor, the G1m1 allotype. Here, we aim to characterize the G1m1 B cells, to disentangle the genetic basis of the B cell response, and to identify the molecular targets.

NCT ID: NCT04963335 Recruiting - Multiple Sclerosis Clinical Trials

Effects of a User-centered Exergame Training on Motor and Cognitive Functions in PwMS

ExergaMS
Start date: March 28, 2021
Phase: N/A
Study type: Interventional

This study examines the feasibility and preliminary effects of user-centered exergames (video game-based physical exercise) in persons with multiple sclerosis (PwMS). The user-centered exergames were developed within a interdisciplinary team to meet the requirements of the end-users. The individualized exergames were designed for the Dividat Senso, a pressure sensitive plate connected to a personal computer and a frontal screen. This concurrent motor-cognitive training aims to improve motor and cognitive functions in an ecological valid setting. The cognitive functions are triggered by specific stimuli in the game scenarios. The video games are controlled via specific (whole body) movements as steps, weight shifting, jumps, and arm movements. The training focus is mainly on balance and coordination as well as executive functions and attention. Furthermore, the meaningful games (colorful and appealing visuals) were designed to motivate the players to move. Participants are allocated to the either the intervention group or the control group (quasi-randomization). Participants in the intervention group perform 16 training session over a period of 4 to 8 weeks (depending on in- or out-patient). One training session lasts between 15-25 minutes. Since the difficulty of the games is adaptive to the ability level of each participant, they should neither be over- nor under-challenged. Participates in the control group continue their normal daily routine over 8 weeks. Measurements are performed before, in-between, and after the intervention period to assess feasibility parameters as well as motor and cognitive functions in all participants.

NCT ID: NCT04956822 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Application of Motor Unit Estimation Index in Amyotrophic Lateral Sclerosis and Related Diseases

Start date: June 1, 2018
Phase:
Study type: Observational

This was a cross-sectional study in which patients were divided into 20 patients with amyotrophic lateral sclerosis, 20 patients with peroneal muscular dystrophy, 20 patients with Kennedy's disease and 30 healthy controls, in which patients with amyotrophic lateral sclerosis continued to be followed up for 1 year and the results of 4 cross-sectional examinations were taken.

NCT ID: NCT04956744 Recruiting - Multiple Sclerosis Clinical Trials

A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis

Start date: August 31, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase 1 study of IMS001, given as a single dose to subjects with Multiple Sclerosis who experience inadequate response and/or intolerability to disease modifying treatments. IMS001 is a human embryonic cell derived (hESC) mesenchymal stem cell (MSC). MSCs have the potential to modulate disease course.

NCT ID: NCT04954573 Recruiting - Clinical trials for Sclerotic Graft-versus-host Disease (GVHD)

Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

This is a prospective, intra-individual comparative study to evaluate the effectiveness of local-water filtered infrared-A (wIRA) irradiation (applied by Hydrosun® radiator 750 for radiation at the clinic, or Hydrosun® 575home for home treatment) in patients with morphea or sclerotic GVHD (Graft-versus-host Disease). The purpose of the study is to determine whether wIRA irradiation can reduce fibrotic skin alterations in circumscribed scleroderma (morphea) or chronic graft versus host disease. wIRA irradiation is applied for 30 minutes 3 times per week for 20 weeks to a diseased skin area and a lesional skin on contralateral body site remains untreated. A total of 22 patients (20 evaluable patients with an expected drop-out rate of 10%) are to be included in this study. Group A: 11 patients with plaque morphea Group B: 11 patients with sclerotic GVHD.

NCT ID: NCT04953624 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Appetite and Related Factors in Patients With ALS

Start date: August 1, 2020
Phase:
Study type: Observational

Chinese cnaq scale was used to evaluate the appetite changes of Chinese ALS patients; Objective to investigate the related factors of appetite changes in ALS patients; Objective to investigate the effect of anorexia on the progression and survival of ALS patients.

NCT ID: NCT04953481 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Home Care Needs and Current Nursing Status of Patients With Amyotrophic Lateral Sclerosis

Start date: January 1, 2021
Phase:
Study type: Observational

The purpose of this study is to comprehensively investigate and analyze the home care needs and status quo of ALS patients in China, and to clarify their home care needs and status quo, so as to provide reference for the development of home care service planning and policy measures for ALS patients.

NCT ID: NCT04952246 Recruiting - Multiple Sclerosis Clinical Trials

Clinical Isolation Syndrome of Spinal Cord and Multiple Sclerosis

Start date: January 1, 2010
Phase:
Study type: Observational

The purpose of this study was to investigate the factors that influence the progression of patients with clinically isolated spinal cord syndrome to multiple sclerosis.

NCT ID: NCT04952038 Recruiting - Clinical trials for Amyotrophic Lateral Sclerosis

Sleep Disorders and the Onset and Progression of ALS

Start date: August 1, 2020
Phase:
Study type: Observational

200 cases of ALS patients were collected to explore whether sleep disorders are related to earlier onset age, and whether sleep disorders accelerate the progress of ALS and shorten the survival time of ALS patients.